Alpine Woods Capital Investors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Alpine Woods Capital Investors’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,801	Closed	-$348K	–	471
2017 Q3	$348K	Buy	3,801 +557	+17%	+$42.7K	0.02%	353
2017 Q2	$215K	Hold	3,244	–	–	0.01%	411
2017 Q1	$704K	Hold	3,244	–	–	0.04%	277
2016 Q4	$300K	Sell	3,244 -1,200	-27%	-$135K	0.02%	362
2016 Q3	$601K	Hold	4,444	–	–	0.03%	294
2016 Q2	$450K	Hold	4,444	–	–	0.03%	310
2016 Q1	$728K	Hold	4,444	–	–	0.04%	267
2015 Q4	$1.46M	Hold	4,444	–	–	0.08%	211
2015 Q3	$1.43M	Hold	4,444	–	–	0.08%	217
2015 Q2	$1.77M	Hold	4,444	–	–	0.09%	195
2015 Q1	$2.19M	Buy	4,444 +1,111	+33%	+$431K	0.11%	182
2014 Q4	$1.19M	Buy	+3,333	New	+$992K	0.06%	233

Other funds holding LUMO

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpine Woods Capital Investors's LUMO Position: Q4 2017 in Review

Alpine Woods Capital Investors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2017, closing a stake of 3,801 shares — an estimated $348K sold.

Alpine Woods Capital Investors first reported a position in LUMO in Q4 2014 and held it in 12 quarters. The position peaked at $2.19M in Q1 2015. 130 funds tracked by Wall St. Rank hold LUMO as of Q4 2017.

Alpine Woods Capital Investors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Alpine Woods Capital Investors sold 3,801 Lumos Pharma, Inc. Common Stock shares in Q4 2017, an estimated $348K.
Alpine Woods Capital Investors first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 12 quarters.
Alpine Woods Capital Investors's Lumos Pharma, Inc. Common Stock position peaked at $2.19M in Q1 2015.
130 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2017.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2017, filed 14 Feb 2018.